user-avatar
Seeking Alpha

Eli Lilly Is Priced for Acceleration While Its Reported Growth Decelerates

Eli Lilly's revenue rose 39% to $24.4 billion. The company raised its full-year guidance by $5.5 billion. However, growth slowed from 49% to 35%.